Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 14;24(18):14116.
doi: 10.3390/ijms241814116.

The P2X7 Receptor in Autoimmunity

Affiliations
Review

The P2X7 Receptor in Autoimmunity

Fabio Grassi et al. Int J Mol Sci. .

Abstract

The P2X7 receptor (P2X7R) is an ATP-gated nonselective cationic channel that, upon intense stimulation, can progress to the opening of a pore permeable to molecules up to 900 Da. Apart from its broad expression in cells of the innate and adaptive immune systems, it is expressed in multiple cell types in different tissues. The dual gating property of P2X7R is instrumental in determining cellular responses, which depend on the expression level of the receptor, timing of stimulation, and microenvironmental cues, thus often complicating the interpretation of experimental data in comprehensive settings. Here we review the existing literature on P2X7R activity in autoimmunity, pinpointing the different functions in cells involved in the immunopathological processes that can make it difficult to model as a druggable target.

Keywords: T cells; autoantibodies; autoimmunity; purinergic signaling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Function of P2X7R in autoimmunity. The diagram shows the general functions of P2X7R in innate and adaptive immunity (center) and peculiar pathogenetic mechanisms involving P2X7R activity in different autoimmune conditions. The possible involvement of P2X7R “loss of function” in Tfh cells in SLE and RA pathogenesis is indicated by a cross on P2X7R. Created with BioRender.

References

    1. Burnstock G. Purinergic Signalling—An Overview. Novartis Found. Symp. 2006;276:26–48; discussion 48–57, 275–281. - PubMed
    1. Di Virgilio F., Dal Ben D., Sarti A.C., Giuliani A.L., Falzoni S. The P2X7 Receptor in Infection and Inflammation. Immunity. 2017;47:15–31. doi: 10.1016/j.immuni.2017.06.020. - DOI - PubMed
    1. Di Virgilio F., Giuliani A.L. Purinergic Signalling in Autoimmunity: A Role for the P2X7R in Systemic Lupus Erythematosus? Biomed. J. 2016;39:326–338. doi: 10.1016/j.bj.2016.08.006. - DOI - PMC - PubMed
    1. Cao F., Hu L.-Q., Yao S.-R., Hu Y., Wang D.-G., Fan Y.-G., Pan G.-X., Tao S.-S., Zhang Q., Pan H.-F., et al. P2X7 Receptor: A Potential Therapeutic Target for Autoimmune Diseases. Autoimmun. Rev. 2019;18:767–777. doi: 10.1016/j.autrev.2019.06.009. - DOI - PubMed
    1. Buell G.N., Talabot F., Gos A., Lorenz J., Lai E., Morris M.A., Antonarakis S.E. Gene Structure and Chromosomal Localization of the Human P2X7 Receptor. Recept. Channels. 1998;5:347–354. - PubMed